ArticleGlobal & regional health technology assessment

Clinical, organizational, and pharmacoeconomic perspectives of dalbavancin vs standard of care in the infectious disease network.

Daniela Segala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.